May 15, 2012

Company announcements: CIMBA40, CIMBC25, PHARMA, KYM

CIMBA40 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE

Announcement Type: General Announcement
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE ASEAN 40 MALAYSIA
Stock Name: CIMBA40
Date Announced: 15/05/2012

Announcement Detail:
Type: Announcement

Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE

Description: Fund: CIMB FTSE ASEAN 40 Malaysia
Date: 15-May-2012
IOPV per unit (RM): 1.6154
Units in circulation (units): 8,100,000.00
Management Fee (% p.a.): 0.00
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.00
FTSE/ASEAN 40 Index: 10,314.83


CIMBC25 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE

Announcement Type: General Announcement
Submitting Merchant Bank: DEUTSCHE BANK (MALAYSIA) BERHAD
Company Name: CIMB FTSE CHINA 25
Stock Name: CIMBC25
Date Announced: 15/05/2012

Announcement Detail:
Type: Announcement

Subject: NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE

Description: Fund: CIMB FTSE China 25
Date: 15-Apr-2012
IOPV per unit (RM): 0.8362
Units in circulation (units): 13,650,000.00
Management Fee (% p.a.): 0.60
Trustee Fee (% p.a.): 0.08
Index Licence Fee (% p.a.): 0.04
FTSE/Xinhua China 25 Index: 15,480.50


PHARMA - Change in Principal Officer

Announcement Type: Change in Principal Officer
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 15/05/2012

Announcement Detail:
Date of change: 01/06/2012

Name: Faizatul Akmar binti Abu Bakar

Age: 45

Nationality: Malaysian

Designation: Chief Financial Officer

Type of change: Resignation

Reason: To pursue her personal interests

Details of any disagreement that he/she has with the Board of Directors: No

Whether there are any matters that need to be brought to the attention of the shareholders: No

Qualifications: Fellow of the Association of Certified Chartered Accountants (ACCA)

Member of Malaysian Institute of Accountants (MIA)

Working experience and occupation: Held various positions with TIME Engineering Group & TIME dotCom Berhad Group from 1995 before appointed as the CFO of TIME dotCom Berhad in 2009.

Family relationship with any director and/or major shareholder of the listed issuer: None

Any conflict of interests that he/she has with the listed issuer or its subsidiaries: None

Details of any interest in the securities of the listed issuer or its subsidiaries: None


PHARMA - Change in Principal Officer

Announcement Type: Change in Principal Officer
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 15/05/2012

Announcement Detail:
Date of change: 01/06/2012

Name: Norai'ni binti Mohamed Ali

Age: 45

Nationality: Malaysian

Type of change: Appointment

Designation: Chief Financial Officer

Qualifications: BA(HONS) Accounting & Finance

Association of Chartered Certified Accountants (ACCA)

Working experience and occupation: 21 years experience in the field of Accounting and Finance and 16 years in management experience. Joined Pharmaniaga in May 2001 as a Deputy General Manager, Group Corporate Finance and was the position held at the point of the take over by the Boustead Holdings Berhad in April 2011. Subsequently promoted to Procurement Director until current date.

Family relationship with any director and/or major shareholder of the listed issuer: None

Any conflict of interests that he/she has with the listed issuer or its subsidiaries: None

Details of any interest in the securities of the listed issuer or its subsidiaries: Pharmaniaga shares 1,980 shares


PHARMA - OTHERS

Announcement Type: General Announcement
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 15/05/2012

Announcement Detail:
Type: Announcement

Subject: OTHERS

Description: APPOINTMENT OF PHARMANIAGA'S CHIEF OPERATING OFFICER


KYM - Additional Listing Announcement

Announcement Type: Additional Listing Announcement (ALA)
Company Name: KYM HOLDINGS BERHAD
Stock Name: KYM
Date Announced: 15/05/2012

Announcement Detail:
Whether the corporate proposal involves the issuance of new type and new class of securities?: No

Types of corporate proposal: Others

Details of corporate proposal: Conversion of Warrants 2010/2013 to ordinary shares

No. of shares issued under this corporate proposal: 5,000

Issue price per share ($$): MYR 0.500

Par Value ($$): MYR 0.500

Units: 116,282,688

Currency: MYR 58,141,344.000

Listing Date: 16/05/2012


No comments:

Post a Comment